Literature DB >> 25038323

Engineering disulfide bonds within an antibody.

Yoshihisa Hagihara1, Dirk Saerens2.   

Abstract

Antibodies have evolved to function in oxidative, extracellular environments. A pair of cysteines in close proximity will oxidatively react to form a disulfide bond that fixes and stabilizes the tertiary structure of a protein. Immunoglobulin G (IgG) includes several disulfide bonds, and the patterns of inter-chain disulfide bonds characterize different IgG sub-classes. Moreover, the Ig-fold domains are characterized by a buried intra-domain disulfide bond, which is important for its structural stability. However, the intra-domain disulfide bond can be replaced without crucial effects on the structure and function, if the domain structure is intrinsically stable or has been stabilized by protein engineering. In previous studies, disulfide bonds were removed by amino-acid substitution indicating that Val and/or Ala (i.e. Ala-Ala, Ala-Val, Val-Ala, and Val-Ala) pairs were preferred for cysteine replacement in the Ig-fold domain. As such, these mutations may be useful for the intracellular use of antibodies. Recently, additional intra-domain disulfide bonds have been shown to stabilize Ig-fold domains and whole IgGs. In heavy chain variable or light chain variable domains, the introduction of additional disulfide bonds into the framework region did not reduce antigen-binding affinity, suggesting that generating disulfide bonds may be a method for stabilizing IgG and antibody fragments, such as the antigen-binding fragment, and single-chain and single-domain antibodies. This article is part of a Special Issue entitled: Recent advances in molecular engineering of antibody.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Antibody fragment; Disulfide bond; Protein engineering; Protein folding; Single domain antibody

Year:  2014        PMID: 25038323     DOI: 10.1016/j.bbapap.2014.07.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

1.  The role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodies.

Authors:  Yoko Akazawa-Ogawa; Koichi Uegaki; Yoshihisa Hagihara
Journal:  J Biochem       Date:  2015-08-19       Impact factor: 3.387

2.  Filtering Next-Generation Sequencing of the Ig Gene Repertoire Data Using Antibody Structural Information.

Authors:  Aleksandr Kovaltsuk; Konrad Krawczyk; Sebastian Kelm; James Snowden; Charlotte M Deane
Journal:  J Immunol       Date:  2018-11-05       Impact factor: 5.422

3.  Evaluation of a noncanonical Cys40-Cys55 disulfide linkage for stabilization of single-domain antibodies.

Authors:  Dae Young Kim; Hiba Kandalaft; Greg Hussack; Shalini Raphael; Wen Ding; John F Kelly; Kevin A Henry; Jamshid Tanha
Journal:  Protein Sci       Date:  2019-03-14       Impact factor: 6.725

Review 4.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

Review 5.  Engineered control of enzyme structural dynamics and function.

Authors:  David D Boehr; Rebecca N D'Amico; Kathleen F O'Rourke
Journal:  Protein Sci       Date:  2018-02-16       Impact factor: 6.725

6.  Molecular Mechanism of MDGA1: Regulation of Neuroligin 2:Neurexin Trans-synaptic Bridges.

Authors:  Shanti Pal Gangwar; Xiaoying Zhong; Suchithra Seshadrinathan; Hui Chen; Mischa Machius; Gabby Rudenko
Journal:  Neuron       Date:  2017-06-21       Impact factor: 17.173

7.  Evaluation of disulfide bond position to enhance the thermal stability of a highly stable single domain antibody.

Authors:  Dan Zabetakis; Mark A Olson; George P Anderson; Patricia M Legler; Ellen R Goldman
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

8.  Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors.

Authors:  Ming Cheng; Brian H Santich; Hong Xu; Mahiuddin Ahmed; Morgan Huse; Nai-Kong V Cheung
Journal:  Oncoimmunology       Date:  2016-05-05       Impact factor: 8.110

9.  Enhanced production of a single domain antibody with an engineered stabilizing extra disulfide bond.

Authors:  Jinny L Liu; Ellen R Goldman; Dan Zabetakis; Scott A Walper; Kendrick B Turner; Lisa C Shriver-Lake; George P Anderson
Journal:  Microb Cell Fact       Date:  2015-10-09       Impact factor: 5.328

10.  Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli.

Authors:  Anna Gaciarz; Johanna Veijola; Yuko Uchida; Mirva J Saaranen; Chunguang Wang; Sohvi Hörkkö; Lloyd W Ruddock
Journal:  Microb Cell Fact       Date:  2016-01-25       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.